Genprex
GNPX
NASDAQ
IPO2018
about GNPX
Genprex is a biopharmaceutical company focused on developing innovative cancer treatments, including immuno-oncology approaches targeting solid tumors.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $9.52 | $9.89 | $6.62 | $8.79M | 4.31M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.17 | n/a | n/a | 0% | 0% | 0% |